(Total Views: 630)
Posted On: 10/04/2024 12:52:56 PM
Post# of 148870
Re: HHIGambler #146881
The word I liked best in the announcement today was "final."
"...The Company’s final study protocol was submitted to the FDA for approval in
September..."
This certainly implies that the FDA like Jay sees it as the final proposal, and we'll be on our way soon. This trial being CRC is important -- not only because so many people get it and die from it, but also because Leron can attack micro-satellite stable colorectal cancer. Nobody else can target the MSS patients, and they comprise 80-85% of the sufferers.
In other words, the results will be miles ahead of any other drug. CRC is a sitting duck.
"...The Company’s final study protocol was submitted to the FDA for approval in
September..."
This certainly implies that the FDA like Jay sees it as the final proposal, and we'll be on our way soon. This trial being CRC is important -- not only because so many people get it and die from it, but also because Leron can attack micro-satellite stable colorectal cancer. Nobody else can target the MSS patients, and they comprise 80-85% of the sufferers.
In other words, the results will be miles ahead of any other drug. CRC is a sitting duck.
(24)
(0)Scroll down for more posts ▼
